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Department of Zoology, University ofCambridge, Dovming St, Cambridge
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SUMMARY

In this study, two cardioactive drugs, acetylcholine (ACh) and the tetrapeptide
FMRFamide, are perfused through the isolated systemic heart of the gastropod,
Busycon canaliculatum. Their effect is examined in terms of the regulation of
output, and is then related to the in vivo regulation of stroke volume.
ACh decreases cardiac output by reducing both stroke volume and heart rate.
End-diastolic volume and cardiac reserve increase with drug concentration. These
effects are accompanied by a slowing in the rise time of the electromyogram
prepotential and an increase in the duration of the plateau phase. Low concentrations
of FMRFamide increase output by accelerating the heart rate. Stroke volume is only
affected at higher concentrations (5XlO~ 7 molP 1 ), and then negatively. Enddiastolic volume is reduced. Between 10~9 and 10~8moll~1, FMRFamide increases
the rise time of the prepotential and the amplitude of the plateau; the duration of the
plateau is markedly shortened. At 5XlO~ 7 moll~ 1 and above, the plateau is extended
and the cardiac reserve is reduced to zero. The two drugs have opposite effects on the
characteristics of the aortic pressure pulse: ACh reduces the amplitude of the pulse,
but increases its duration.

INTRODUCTION

Factors modulating cardiac output are often examined separately, although in vivo
they would act in concert. This is particularly apparent in the treatment of intrinsic
and extrinsic modulation. Although this approach has obvious advantages, it can
result in data which are difficult to relate to cardiac performance in the whole animal,
a situation which has certainly occurred in studies on molluscan cardiovascular
physiology. This paper, the third in a series (Smith, 1985a; Smith & Hill, 1986) uses
the systemic heart of Busycon canaliculatum to examine some basic parameters of
cardiac modulation in vitro, with the aim of extending and eventually testing the
conclusions on an in vivo preparation.
The energetics and intrinsic modulation of the Busycon heart, under various
x>reload and afterload perfusion pressures, have already been examined (Smith,
Wey words: heart, cardiac performance, acetylcholine, FMRFamide, Busycon, gastropod.
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1985a). The performance of the heart is predictable, with stroke volume varying in
direct proportion to the preload value. In this respect, the Busycon heart conforms to
Starling's law, as do the ventricles of two other molluscs examined, Aplysia and
Eledone (Straub, 1901, 1904; Smith, 1981).
Intrinsic modulation will act in vivo in conjunction with such extrinsic effects as
the action of cardioactive neurotransmitters. In Busycon, for example, 5-hydroxytryptamine (5-HT) alters heart rate in a dose-dependent manner, but has little or no
effect on stroke volume (Smith & Hill, 1986). It does, however, have a profound
effect on the manner in which the blood is ejected from the heart. Pressure pulse
amplitude rises with 5-HT concentration at constant perfusion pressures, but the
duration of the pulse drops in such a way that the stroke volume remains relatively
constant.
The present study examines the action of two further putative cardioregulatory
substances in the mollusc: the tetrapeptide FMRFamide (Phe-Met-Arg-Phe-NH2)
and acetylcholine (for reviews see Jones, 1983; Painter & Greenberg, 1982). The
emphasis is not on the pharmacological action of these two drugs, but on how they
might contribute to the dynamic regulation of cardiac output, working in parallel
with other cardioregulatory substances and the intrinsic properties of the myocardium. For this reason, attention is paid, not only to the effects on stroke volume
and heart rate, but also to the manner of fluid ejection and the ventricular enddiastolic volume. These results are compared with changes in the electromyogram.

MATERIALS AND METHODS

The subject of this study was the prosobranch mollusc, Busycon canaliculatum
(L.). The work was conducted at the Department of Zoology, University of Rhode
Island, USA, during the months of March and April, 1985. Animals came from the
Marine Biological Laboratory, Woods Hole and were maintained in a recirculating
aquarium at a temperature of 20°C. This was also the experimental temperature.
The procedure for isolating and perfusing the heart of B. canaliculatum has
already been described in detail in previous publications (Smith, 1985a; Smith &
Hill, 1986). Briefly, the isolated systemic heart (atrium and ventricle), removed from
the constraints of the pericardium, was perfused at controlled levels of preload (input
perfusion pressure) and afterload (output back pressure). Cardiac responses to
changes in the experimental conditions were assessed in terms of: stroke volume
[mean measured output over a known number of beats (approximately 20)]; heart
rate measured over a 2- to 3-min period; pressure pulse characteristics; electromyograms recorded with surface suction electrodes; and gross changes in ventricular
end-diastolic volume. Except for changes in the ventricular volume, the methods of
collecting and recording the data have been described in detail before (Smith,
1985a).
The cardiac volume was recorded crudely with a rotary motion transducer
(Harvard, Model 356) equipped with a light wooden stick which was arranged so a4
to rest against the surface of the heart. As the volume of the heart changed, the sticic
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moved. The output signal was amplified using a Grass Low Level d.c. preamplifier
(7P1B) coupled to the Grass Driver Amplifier (7DA) on a Grass Polygraph (76C).
The results were unitless and serve only to monitor heart size during the diastolic
pause.
Hearts were perfused both internally and externally with the test solutions. Two
header-tanks connected to a single input reservoir allowed a rapid change-over from
one perfusate to another, without interruption of either the pressure or flow of fluid
to the heart (Smith & Hill, 1986). In contrast to the 5-HT study (Smith & Hill,
1986), the effects of acetylcholine iodide (ACh: Sigma) or FMRFamide (Cambridge
Biochemicals) on cardiac performance were not examined over a range of preload
values. Instead, the preload was fixed at 4cmH 2 O (1 cmH 2 0 = 98-1 Pa) with an
afterload of 6cmH 2 O. A fresh preparation was used for every experiment. The two
drugs were never tested on the same heart.
The drugs were tested in ascending concentrations, a time-consuming procedure.
To check against the deterioration of the preparation during a concentration series,
the hearts were perfused with sea water for about lOmin between tests, and the
performance was compared to the initial, control, run. No obvious deterioration was
observed. All test solutions were made up either freshly in filtered sea water or, in the
case of FMRFamide, from samples of 10~4moll~1 solutions stored at —70°C.
Fig. 1 shows the relationship between stroke volume and ventricular wet mass
(measured as described by Smith, 1985a) for both sexes and at two different
conditions of loading. The stroke volumes of hearts from the previous two studies are
included. The relationship is non-linear. As cardiac volume might be expected to
increase with the square of the mass, power curves, with the equations given in the
figure, were fitted to the data. No ventricle heavier than of 0-7 g was used, so the
behaviour of this relationship above that mass is not known. Stroke volume was
corrected for ventricular size using the equation for a preload of 4cmH2O and an
afterload of 6cmH 2 O and was expressed in ml0-5 g" 1 ventricular wet mass. The
mean heart masses were 0-46g (±0-08s.D.) and 0-36g (±0-1 S.D.) for the ACh and
FMRFamide experiments, respectively.
Since the performance of preparations varies considerably and independently of
heart mass (Fig. 1), the response to drugs and pressure changes also varies, even after
correction for mass. Therefore, quantitative comparisons between preparations, or
between the in vitro and in vivo conditions, should be made cautiously. However,
the qualitative responses to either pressure change (Smith, 1985a) or drug application (Smith & Hill, 1986; this study) are similar in all preparations and will
therefore be emphasized in this report.
RESULTS

Effects of acetylcholine (ACh)
The response of the heart to ACh was tested over a concentration range of 10~14 to
10~ 6 moll~'. Only the results from concentrations greater than 10 moll" 1 are
shown in Figs 2—5. Threshold appeared to lie above 10~ 9 molP 1 .
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Fig. 1. The relationship between ventricular wet mass and stroke volume (SV) at two
different, but constant, perfusion levels. ( • ) Preload 6cmH2O, afterload 8cmH2O;
upper curve. (O) Preload 4cmH2O, afterload 6cmH2O; lower curve. The sex of four
animals was not noted. Preparations used to measure the effects of acetylcholine (•) and
FMRFamide (|) on stroke volume and heart rate are marked.

ACh acts upon the heart to reduce cardiac output (stroke volume X heart rate).
This is achieved by a reduction in both the stroke volume (Fig. 2A) and the heart rate
(Fig. 2B). The response is dose-dependent. Stroke volume began to show a clear
decline at 5X 10 -8 moll~ 1 , whereas heart rate was reduced at 10~ 8 molP 1 . At these
concentrations, returning the heart to sea water after perfusion with the drug caused
a return to control values. As the concentration was increased, however, there was an
after-effect which did not wash out during an intermediate period of sea water
perfusion. This effect, an increase of both the stroke volume and the heart rate, was
dependent on the preceding ACh concentration. At 10~ 6 moll~', ACh arrested the
heart.
Increasing the concentration of ACh also altered the characteristics of the aortic
pressure pulse. The perfusate was ejected from the heart over a longer period
(Fig. 3A) but at a lower pressure (Fig. 3B). On return to normal sea water, however,
there was no appreciable change in the pressure pulse duration compared to the control value, but there was a clear increase of the amplitude. Thus the change in stroke
volume on wash-out was accommodated purely by an amplitude increase acting
against a fixed resistance (the afterload). The wash-out increase in heart rate was not
the result of an accelerated systolic pulse, as this period was unaltered (Fig. 3A).

Cardiac modulation in Busycon

109

1-21- A

10

0-8

'«, 0-6
o

1

0-4

00 « -

l

14 r

B

UT 6

12

10

2

6

01—
Concentration of acetylcholine (mo) ]

)

Fig. 2. Effect of acetylcholine (ACh, O) on the stroke volume (A) and heart rate (B).
Before perfusion with a new concentration of ACh the hearts were washed out with sea
water ( • ) . At about 10~ 8 moll~ 1 ACh reduces both stroke volume and the rate of
contraction. On washing out, however, these values increase (Ar = 6; s.E. is shown on one
side of each mean value).
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Fig. 3. Effect of acetylcholine (ACh, 0 ) on the aortic pressure pulse duration (A) and
amplitude (B). The results have been normalized relative to the values recorded in sea
water at the onset of the experiment (10~ 1 4 moir 1 ACh) and show a threshold around
5XlO~ 9 moll~'. The original charactenstics of the pressure pulse were: mean amplitude,
2-75cmH2O; duration, 3-4 s. Unlike the effect on rate and stroke volume, washout with
sea water ( • ) returns the pulse duration to the control value but the amplitude remains
elevated above l O ^ m o U - 1 (A r =9).
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As with the physical performance of the heart, the electrical activity was first
clearly affected by ACh between of 10~8 and 5 X 10~8 mol I"1 (Fig. 4). The effect was
progressive, with increased concentrations causing an increased slowing of the
prepotential and an increased prolongation of the plateau. The spike became less
obvious as concentration increased and the plateau amplitude declined. Changes in
the degree of suction will affect the electromyogram amplitudes, so this aspect of the
results should be treated with caution. At lO^molF 1 the heart was arrested, but
reversibly (as shown in the bottom traces of Fig. 4).
The results in Fig. 4 all come from the same preparation and do not show an aftereffect, as the heart was perfused with a high concentration of acetylcholine (10~6
moll" 1 ) prior to recording the electromyogram. This gave a more stable electrical
recording. Hearts perfused for the first time with acetylcholine (N = 4) showed
basically the same result but the suction, which held the electrode in place on the
myocardium, invariably broke down during the recording period.
Fig. 5A,B shows examples of how ACh, at two concentrations, affects ventricular
volume and aortic pressure pulse, the greater concentration causing arrest. In both
cases it is clear that in addition to either greatly reducing or stopping the aortic
pressure pulse, ACh also relaxed the myocardium. This resulted in a ventricular
volume increase, although the preload level remained the same. The end-systolic
volume, the cardiac reserve, also appeared to be increased. This would be inevitable
if end-diastolic volume were increasing while stroke volume was decreasing with
ACh concentration, as shown in Fig. 2A.
Effects of FMRFamide
FMRFamide, between 10~ and 5xlO~ 7 moll~ 1 , increased cardiac output. This
was achieved entirely by an increase in the heart rate, as no positive effect of
FMRFamide on stroke volume was observed (Fig. 6A,B). Despite the variation
around the mean values in Fig. 6A and 6B all the preparations showed exactly the
same trend. Above 10~7moll~1 the stroke volume began to decline, as did the heart
rate at 5XlO~ 7 moll~ 1 . In the latter case, washing-out with sea water between
concentrations returned the heart to control levels.
As with ACh, FMRFamide affected the characteristics of the aortic pressure pulse
(Fig. 7A,B). It increased the pulse amplitude while decreasing its duration, an effect
upon the ventricle opposite to that of ACh. The perfusate was therefore being ejected
at a higher pressure, but over a shorter time. Flow-rate increased. Both responses
showed a threshold at approximately 10~ 9 -SXl0~ 9 molP 1 , balancing one another
out in such a way that there was no effect on the stroke volume until 5 X10 mol 1~ .
At lower concentrations (10~ 8 -10~ 7 moll~') FMRFamide acted on the electromyogram to reduce the duration of both the prepotential and the plateau; spike
and plateau amplitude both increase (Fig. 8). This corresponds to an acceleration of
beat frequency and rapid change in the pressure pulse characteristics (Figs 6B-8).
At concentrations of 5xlO~ 7 -10~ 6 moll~ 1 the electromyogram form changed dramatically, with the plateau phase being greatly extended. Heart rate dropped at
8
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Controls perfused with sea water

Application of acetylcholine

10~ 9 moir'

AAAAA J W W
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4mV
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AAAAA
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Sea water

10~6mol P '

15s

Sea water

Fig. 4. Effect of acetylcholine (ACh) perfusion on the ventricular electromyogram and
aortic pressure pulse. The left-hand column shows the activity in sea water prior to the
application of ACh. Increasing concentrations decrease the amplitude of the pressure
pulse (lower record) but increase the duration of both this and the electromyogram
(upper record). Note the change in the time base in the last series of records.
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these concentrations (Fig. 6B) as a result of the failure of the myocardium to
repolarize in the normal time.
The effect of FMRFamide on ventricular volume is opposite to that of acetylcholine. End-diastolic volume decreased in a dose-dependent manner (Fig. 9).
Visual observations also indicated that, at the higher concentration, the myocardium
was rapidly contracted with no appreciable end-systolic reserve. This explains why
there was such a rapid and short pressure pulse (Figs 7A, 8) while the plateau
duration of the electromyogram was sustained (Fig. 8); all of the perfusate was
ejected over the initial period of systolic contraction.

Decrease in volume

Increase in volume

4cmH2O
Pressure pulse

Sea water

Decrease in volume

Increase in volume

4cmH2O
Pressure pulse

2min

5xl<r'moll -1

Sea water

Fig. 5. The effect of acetylcholine (ACh) on the ventricular volume and pressure pulse at
(A) 10~ 7 moir' and (B) 5XlO" 7 moir'. The higher concentration arrests the heart.
ACh relaxes the tone of the heart allowing a larger end-diastolic volume for the same
preload value (in this case, 4cmH2O).
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concentrations above SXlCP'moll" 1 , but the action is reversed above 10~ 7 moll~'.
Between doses of peptide the hearts were washed out with sea water ( • ) returning the
performance to control values (N = 5; S.E. is shown on one side of the mean value).
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Fig. 7. Effect of FMRFamide on the aortic pressure pulse duration (A) and amplitude
(B, O). The data has been normalized relative to the initial values obtained during sea
water perfusion. The original characteristics of the pressure pulse were: mean amplitude,
3-4cmH2O; duration, 4-0s. Values in sea water prior to each perfusion with FMRFamide are shown by solid symbols. Both amplitude and duration are affected at
concentrations above 10~ 9 moll~'. Single standard errors are shown on one side of the
mean values (N = 6).
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DISCUSSION
In the isolated Busy con heart, ACh reduces cardiac output (stroke volume X heart
rate) by its effect on both heart rate and stroke volume. The reduction in beat
Controls perfused with sea water

Application of FMRFamide
io- 8 moir 1

5xlO"8moir1

AAfXAAP

4mV

4cmH2O

4s

4mV

4cmH2O [

10"7moir1

AAAAAA

J\J\J\J\Jll

Fig. 8. Effect of FMRFamide on the ventricular electromyogram and aortic pressure
pulse. Initially there is a shortening of the plateau duration and an accelerated rise of the
prepotential. At higher concentrations the plateau duration is greatly extended and the
rate drops. Note that the scale of the pressure pulse amplitude changes at 10~7 mol T 1 .
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frequency is reflected by a slowing in the rate of rise of the prepotential and an
increase in the duration of the plateau. The latter corresponds to an increase in the
duration of the aortic pressure pulse, but the amplitude of the pressure pulse,
working against a constant pressure difference, decreases with ACh concentration.
The end-diastolic volume increases with ACh concentration.
Decrease in volume

Increase in volume

Pressure pulse -

I

5xlO" 8 moll" 1

Sea water

4cmH2O

2min
Sea water

l(r 6 moll - 1

Sea water

Fig. 9. The effect of FMRFamide on the ventricular volume and pressure pulse at three
different concentrations. Here the ventricular volume is decreased at the end of diastole.
The pulse pressure has been omitted from the last concentration.
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At lower concentrations, FMRFamide acts in a manner opposite to that of ACh;
cardiac output is increased. This is achieved solely by an increase in heart rate, as
there is no indication that FMRFamide alters stroke volume. These responses
correspond to a more rapid rise in the prepotential and a shortening of the plateau
duration, making the action of FMRFamide, at concentrations below 10~ mol 1~ ,
similar to those of 5-HT (Smith & Hill, 1986). Also, as with 5-HT, the pressure
pulse amplitude is greatly increased while the duration decreases. Simultaneously,
the duration of the electromyogram plateau is reduced while the amplitude increases.
However, above 10~7moll~1 FMRFamide, both heart rate and stroke volume
decline dramatically. This is not caused by the kind of cardiac inhibition produced by
ACh, but by an extreme extension of the action potential plateau, perhaps as a result
of the membrane failing to repolarize. [After washout of the FMRFamide the
controls can show incomplete repolarization (Fig. 8, bottom left).] A similar plateau
extension also occurs in calcium-free sea water (P. J. S. Smith, unpublished
observation). Stroke volume declines as FMRFamide decreases the end-diastolic
volume and the heart simply expels its entire content.
The results of this study seem to contradict the previously reported effects
of ACh. In various molluscan species, Crassostrea gigas (Irisawa, Kobayashi &
Matsubayashi, 1961), Modiolus demissus granosissimus (Wilkens & Greenberg,
1973) and Dolabella auricularia (Hill, 1974), the application of ACh leads to a
reduction in the duration of the plateau. In the latter two studies this was correlated
with a reduction in the force of contraction. However, the different species and
experimental regimes used in the different studies complicate any comparison. In
the present investigation, the heart, influenced by both intrinsic and extrinsic
modulating factors which affect the form of the action potential (see also Smith,
1985a), works against an after-load while being perfused with the cardioactive
substances. In addition it is being stretched internally during diastole by the preload
levels. These experiments therefore reflect a complex interaction of regulatory
mechanisms, making the results difficult to compare with the simpler force of
contraction measured in earlier work. Despite these difficulties the perfused working
heart is a better preparation for examining the regulation of output.
The reasons for the change in the action of FMRFamide at higher concentrations
and the rebound effect after perfusion with acetylcholine cannot be answered from
this study. These effects may reflect changes in the ionic permeabilities of the
membrane or some persistent intracellular action.
Cardiac performance in the molluscs has a number of features in common with
the lower vertebrates, most notably that changes in output may be primarily
accommodated by altering stroke volume and not heart rate (for review see Smith,
19856). This point is clearly seen in the cephalopod mollusc, Octopus vulgaris,
where a five-fold increase in stroke work (stroke volume X the pressure difference
across the heart) accompanies exercise. Using indirect methods, Thompson,
Livingston & de Zwaan (1980) showed similar changes in ventricular volume for the
scallop. These authors have further shown that it is the end-diastolic volume which
increases, proving that changes in stroke volume are not achieved solely by a
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reduction in the end-systolic volume. Observations such as these, even if still
indirect, do raise the interesting question of how stroke volume might be controlled
in the molluscs.
The work on the isolated systemic heart of Busycon has shown that none of the
three most obvious cardioactive substances can act alone to increase stroke volume.
Regulation could, however, be achieved by the phasic action of the cholinergic
innervation at the end of ventricular systole allowing the heart to achieve a greater
volume for the same returning venous pressure. This could facilitate an increase
in output either by an intrinsic reflex mechanism, perhaps similar to the rebound
effect seen in this study, or by aminergic excitation of the myocardium at the onset
of systole. Cholinergic innervation to the prosobranch heart has been shown
(Kawakami & Kobayashi, 1984).
Cholinergic regulation of ventricular relaxation state, causing an increase in the
end-diastolic volume, is already suggested by results from the opisthobranch/lp/ysta.
Koester, Mayeri, Liebeswar & Kandel (1974) noticed that a pattern of cholinergic
neuronal discharge to the heart occurs with the stereotyped repetitive behaviour
during which fresh sea water flows over the gills; the gills contract, pumping an
increased volume of oxygenated blood to the heart, which is then in a relaxed state as
a result of the neuronal activity.
FMRFamide and 5-HT have several similar effects on cardiac performance in the
isolated Busycon heart (this study; Smith & Hill, 1986). The action of both can be
accompanied by increases in the level of cyclic AMP, although FMRFamide is not
affected by the serotonergic antagonist methysergide (see Painter, 1982). However,
with regards to the in vivo action of FMRFamide on cardiac performance, there are
still clear problems in interpreting its role. Both FMRFamide and FMRFamide-like
peptides, such as pQDPFLRFamide, are present in molluscan blood at concentrations around 10~ 9 moir' (Nagle, 1982; Price et al. 1985). This concentration
suggests that the peptides may be acting as circulating hormones with, as individual
concentrations vary (Price et al. 1985), a modulating myotonal effect on their target
organs. Unfortunately, it is not clear that FMRFamide acts on the heart in vivo, or,
if it does, what aspect of cardiac function it might regulate (see Greenberg & Price,
1980).
In considering the actions of cardioactive peptides in vivo, it is worth
remembering that none of the factors which regulate cardiac performance will act in
isolation. This is clearly the case if these peptides circulate above threshold
concentrations. Under these conditions, the cardiac tone will be set on a sliding scale,
depending on the concentration present. Against this tone, other extrinsic or
intrinsic factors will act. Thus, the activity of the cholinergic and aminergic
innervation will be an integral part of an orchestrated response to regulate cardiac
output at defined pressures. In this sense, to categorize cardioactive agents as either
inhibitor}' or excitatory, with regards to cardiac output and performance, is too
simplistic.
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